A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder.
Bipolar Disord. 2020 Nov;22(7):739-748. doi: 10.1111/bdi.12912. Epub 2020 Apr 20.
Bipolar Disord. 2020.
PMID: 32276301
Clinical Trial.